31 May 2021
Sally Amanuel

Sally has over 20 years’ experience working in Regulatory Affairs and Compliance. As a regulatory expert she has a proven track record in driving transformational changes and delivering business results in highly regulated environments across Pharma, Biotech and CRO industries.
In her earlier role at Ergomed as the Head of the Regulatory Affairs and Clinical Delivery, Sally was responsible for integrating the CRO Regulatory function within PrimeVigilance, consolidating the PV Network, XEVMPD, Regulatory Intelligence and Regulatory Affairs teams. Prior to joining Ergomed, Sally held numerous leadership positions at WCT, PPD and Syneos as well as Biogen, Pfizer and GSK, where she led several successful turnarounds, redesigned and expanded service capabilities to exceed revenue targets and provided executive leadership on numerous companywide change initiatives.
Sally gained a BSc in Biotechnology from University College London (UCL), an MA in Biotechnological Law and Ethics from the University of Sheffield and an MBA from the University of Liverpool.